β1-adrenoceptor Arg389Gly polymorphism and heart disease: marching toward clinical practice integration

Pharmacogenomics. 2015;16(10):1035-8. doi: 10.2217/pgs.15.104. Epub 2015 Aug 28.

Authors

Katie A McCrink¹, Anastasios Lymperopoulos¹

Affiliation

¹ Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy, 3200 S. University Dr., HPD (Terry) Bldg/Room 1338, Ft Lauderdale, FL 33328-2018, USA.

PMID: 26314313
DOI: 10.2217/pgs.15.104

No abstract available

Keywords: GWAS; cardiovascular disease; dobutamine; drug response; heart failure; hypertension; polymorphism; β-blocker; β1-adrenergic receptor.

Publication types

Editorial

MeSH terms

Animals
Heart Diseases / genetics*
Humans
Polymorphism, Genetic / genetics*
Receptors, Adrenergic, beta-1 / genetics*

Substances

Receptors, Adrenergic, beta-1